{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:31:33Z","timestamp":1792704693742,"version":"4.5.0"},"reference-count":105,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"abstract":"<jats:sec id=\"ab-ysc260004-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Psychiatric disorders are a major source of disability and premature mortality worldwide. Advances in genomics have clarified parts of their genetic architecture, prompting questions about whether genomic information can inform preventive strategies for psychiatric disorders in clinical practice. This Special Communication describes potential benefits and harms of using genomic information, particularly polygenic scores (PGSs) and rare variants, to guide prevention in psychiatry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ysc260004-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>Broad application of genomic testing in universal or selective primary prevention is not currently supported by evidence of net clinical benefit, given modest absolute risk differences, limited individual-level predictive performance, and the potential for psychological harm. The possible value of genomic testing increases for indicated primary prevention, as prior probability rises and diagnostic uncertainty becomes clinically relevant. The most compelling opportunity lies in early care after individuals enter the psychiatric treatment system but before diagnostic trajectories fully crystallize. In this zone of diagnostic uncertainty, testing for rare, high-impact variants can shorten diagnostic delays, inform prognosis, and guide monitoring and treatment, provided that results are communicated appropriately. PGSs may contribute to risk stratification when applied in high-risk clinical populations and integrated with nongenetic factors. In secondary and tertiary prevention, pharmacogenomics provides actionable benefits for medication choice and safety, and rare variant testing has clear value in selected instances. Beyond psychiatric outcomes, genomic testing could potentially help address the profound mortality gap in severe mental illness by identifying elevated risk for somatic comorbidities, thus supporting more proactive, integrated care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ysc260004-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Currently, genomic testing in psychiatry should not be used for population-wide screening but may have value as a targeted clinical resource whose utility depends on timing, context, and purpose. When applied judiciously and embedded within comprehensive, ethically grounded care pathways, genomic testing holds promise as one component of a more precise, preventive, and patient-centered psychiatry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2026.2583","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:30:40Z","timestamp":1787758240000},"source":"Crossref","is-referenced-by-count":1,"title":["Potential for Genomics to Help Guide Preventive Strategies in Psychiatry"],"prefix":"10.1001","author":[{"given":"Katherine L.","family":"Musliner","sequence":"first","affiliation":[{"name":"Department of Affective Disorders, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva C.","family":"Schulte","sequence":"additional","affiliation":[{"name":"University of Bonn, University Hospital Bonn, Department of Psychiatry & Psychotherapy, Bonn, Germany"},{"name":"University of Bonn, University Hospital Bonn, Institute of Human Genetics, Bonn, Germany"},{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, LMU Munich, Munich, Germany"},{"name":"German Center for Mental Health, partner site Munich-Augsburg, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerome","family":"Breen","sequence":"additional","affiliation":[{"name":"Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"National Institute for Health and Care Research Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fanelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Udine, Udine, Italy"},{"name":"Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas J.","family":"Forstner","sequence":"additional","affiliation":[{"name":"University of Bonn, University Hospital Bonn, Institute of Human Genetics, Bonn, Germany"},{"name":"Institute of Neuroscience and Medicine, Research Center J\u00fclich, J\u00fclich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Jansen","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, Department of Human Genetics, University of Amsterdam, Amsterdam, Netherlands"},{"name":"Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley M.","family":"Kendall","sequence":"additional","affiliation":[{"name":"Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurjen","family":"Luykx","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, the Netherlands"},{"name":"Amsterdam Neuroscience and Public Health Research Institutes, Amsterdam, the Netherlands"},{"name":"GGZ inGeest Mental Health Care, Amsterdam, the Netherlands"},{"name":"Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Millischer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Clinical Division of General Psychiatry, Medical University of Vienna, Vienna, Austria"},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria"},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Papiol","sequence":"additional","affiliation":[{"name":"Institute of Psychiatric Phenomics and Genomics, University Hospital, LMU Munich, Munich, Germany"},{"name":"Max Planck Institute of Psychiatry, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Vassos","sequence":"additional","affiliation":[{"name":"Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"National Institute for Health and Care Research Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Chaumette","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, NeuroDiderot, Institut Pasteur, GHU Paris Psychiatrie et Neurociences, Paris, France"},{"name":"Department of Psychiatry, McGill University, Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter J.","family":"Peyrot","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands"},{"name":"Amsterdam Public Health, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"1","key":"ysc260004r1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12888-025-06932-y","article-title":"Global burden of mental disorders in 204 countries and territories, 1990-2021: results from the global burden of disease study 2021.","volume":"25","author":"Fan","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"8","key":"ysc260004r2","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1038\/s41380-022-01586-8","article-title":"Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review.","volume":"27","author":"Dragioti","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"1","key":"ysc260004r3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/wps.21160","article-title":"The social determinants of mental health and disorder: evidence, prevention and recommendations.","volume":"23","author":"Kirkbride","year":"2024","journal-title":"World Psychiatry"},{"issue":"7","key":"ysc260004r4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/ng.3285","article-title":"Meta-analysis of the heritability of human traits based on fifty years of twin studies.","volume":"47","author":"Polderman","year":"2015","journal-title":"Nat Genet"},{"issue":"8","key":"ysc260004r5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S2215-0366(25)00124-5","article-title":"The Psychiatric Genomics Consortium: discoveries and directions.","volume":"12","author":"Agrawal","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"ysc260004r6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2019.01.015","article-title":"Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders.","volume":"177","author":"Sullivan","year":"2019","journal-title":"Cell"},{"issue":"5","key":"ysc260004r7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41588-022-01034-x","article-title":"Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophrenia.","volume":"54","author":"Palmer","year":"2022","journal-title":"Nat Genet"},{"issue":"7906","key":"ysc260004r8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","article-title":"Rare coding variants in ten genes confer substantial risk for schizophrenia.","volume":"604","author":"Singh","year":"2022","journal-title":"Nature"},{"issue":"31","key":"ysc260004r9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215632120","article-title":"The contributions of rare inherited and polygenic risk to ASD in multiplex families.","volume":"120","author":"Cirnigliaro","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ysc260004r10","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1038\/s41380-022-01536-4","article-title":"Exome-wide screening identifies novel rare risk variants for major depression disorder.","volume":"27","author":"Cheng","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"8098","key":"ysc260004r11","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41586-025-09702-8","article-title":"Rare genetic variants confer a high risk of ADHD and implicate neuronal biology.","volume":"649","author":"Demontis","year":"2026","journal-title":"Nature"},{"issue":"6","key":"ysc260004r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2025.101398","article-title":"A meta-analysis of diagnostic yield and clinical utility of genome and exome sequencing in pediatric rare and undiagnosed genetic diseases.","volume":"27","author":"Pandey","year":"2025","journal-title":"Genet Med"},{"issue":"11","key":"ysc260004r13","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/s41436-019-0554-6","article-title":"Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.","volume":"21","author":"Srivastava","year":"2019","journal-title":"Genet Med"},{"issue":"23","key":"ysc260004r14","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1016\/j.cell.2022.10.009","article-title":"Genomic architecture of autism from comprehensive whole-genome sequence annotation.","volume":"185","author":"Trost","year":"2022","journal-title":"Cell"},{"issue":"12","key":"ysc260004r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2025.101598","article-title":"Common and rare genetic variants explain distinct diagnostic variance in pediatric attention deficit hyperactivity disorder.","volume":"27","author":"Arnett","year":"2025","journal-title":"Genet Med"},{"issue":"7","key":"ysc260004r16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.biopsych.2025.09.010","article-title":"Clinical genetic testing in schizophrenia: a systematic review and meta-analysis.","volume":"99","author":"Brah","year":"2026","journal-title":"Biol Psychiatry"},{"issue":"1","key":"ysc260004r17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamapsychiatry.2020.3049","article-title":"From basic science to clinical application of polygenic risk scores: a primer.","volume":"78","author":"Wray","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"ysc260004r18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/jamapsychiatry.2020.3042","article-title":"Could polygenic risk scores be useful in psychiatry: a review.","volume":"78","author":"Murray","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"ysc260004r20","first-page":"107","article-title":"An operational classification of disease prevention.","volume":"98","author":"Gordon","year":"1983","journal-title":"Public Health Rep"},{"issue":"7","key":"ysc260004r22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S2215-0366(18)30057-9","article-title":"Preventive strategies for mental health.","volume":"5","author":"Arango","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"ysc260004r23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/wps.20869","article-title":"Preventive psychiatry: a blueprint for improving the mental health of young people.","volume":"20","author":"Fusar-Poli","year":"2021","journal-title":"World Psychiatry"},{"issue":"6","key":"ysc260004r24","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1038\/s41380-025-02902-8","article-title":"Preventing psychosis in people at clinical high risk: an updated meta-analysis by the World Psychiatric Association Preventive Psychiatry section.","volume":"30","author":"Minichino","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"2","key":"ysc260004r25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/wps.20423","article-title":"A critique of the \u201cultra-high risk\u201d and \u201ctransition\u201d paradigm.","volume":"16","author":"van Os","year":"2017","journal-title":"World Psychiatry"},{"key":"ysc260004r26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12991-014-0027-x","article-title":"Psychiatric manifestations of treatable hereditary metabolic disorders in adults.","volume":"13","author":"Demily","year":"2014","journal-title":"Ann Gen Psychiatry"},{"issue":"suppl 1","key":"ysc260004r27","doi-asserted-by":"publisher","first-page":"1s","DOI":"10.1097\/01.gim.0000223891.82390.ad","article-title":"Newborn screening: Toward a uniform screening panel and system.","volume":"8 suppl 1","author":"Watson","year":"2006","journal-title":"Genet Med"},{"issue":"2","key":"ysc260004r28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/ijns10020038","article-title":"Current status of newborn bloodspot screening worldwide 2024: a comprehensive review of recent activities (2020-2023).","volume":"10","author":"Therrell","year":"2024","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"ysc260004r29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/jama.2024.19662","article-title":"Expanded newborn screening using genome sequencing for early actionable conditions.","volume":"333","author":"Ziegler","year":"2025","journal-title":"JAMA"},{"issue":"4","key":"ysc260004r30","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41591-024-03465-x","article-title":"Population-based, first-tier genomic newborn screening in the maternity ward.","volume":"31","author":"Boemer","year":"2025","journal-title":"Nat Med"},{"issue":"17","key":"ysc260004r31","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/hmg\/ddq259","article-title":"Penetrance for copy number variants associated with schizophrenia.","volume":"19","author":"Vassos","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"2","key":"ysc260004r32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11920-008-0026-1","article-title":"Schizophrenia and 22q11.2 deletion syndrome.","volume":"10","author":"Bassett","year":"2008","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"ysc260004r33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","article-title":"Identification of common genetic risk variants for autism spectrum disorder.","volume":"51","author":"Grove","year":"2019","journal-title":"Nat Genet"},{"issue":"2","key":"ysc260004r34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41588-022-01285-8","article-title":"Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains.","volume":"55","author":"Demontis","year":"2023","journal-title":"Nat Genet"},{"issue":"12","key":"ysc260004r35","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41576-025-00843-0","article-title":"Genomics of schizophrenia, bipolar disorder and major depressive disorder.","volume":"26","author":"Owen","year":"2025","journal-title":"Nat Rev Genet"},{"issue":"4","key":"ysc260004r36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jamapsychiatry.2020.4172","article-title":"Risk of early-onset depression associated with polygenic liability, parental psychiatric history, and socioeconomic status.","volume":"78","author":"Agerbo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"ysc260004r37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamapsychiatry.2018.4166","article-title":"Association of polygenic liabilities for major depression, bipolar disorder, and schizophrenia with risk for depression in the Danish population.","volume":"76","author":"Musliner","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"ysc260004r38","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2026.1064","article-title":"Recurrent copy number variants and psychiatric outcomes in the context of polygenic scores.","author":"Vaez","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"ysc260004r39","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1176\/appi.ajp.157.10.1552","article-title":"Genetic epidemiology of major depression: review and meta-analysis.","volume":"157","author":"Sullivan","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"11","key":"ysc260004r40","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1037\/ccp0000254","article-title":"Testing positive for a genetic predisposition to depression magnifies retrospective memory for depressive symptoms.","volume":"85","author":"Lebowitz","year":"2017","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"ysc260004r41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s10897-017-0140-5","article-title":"Blue genes\u2014understanding and mitigating negative consequences of personalized information about genetic risk for depression.","volume":"27","author":"Lebowitz","year":"2018","journal-title":"J Genet Couns"},{"issue":"1","key":"ysc260004r42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13073-022-01117-8","article-title":"Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization.","volume":"14","author":"Lewis","year":"2022","journal-title":"Genome Med"},{"issue":"3","key":"ysc260004r43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/wps.20773","article-title":"A meta-review of \u201clifestyle psychiatry\u201d: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders.","volume":"19","author":"Firth","year":"2020","journal-title":"World Psychiatry"},{"issue":"2","key":"ysc260004r44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1017\/S0033291719000035","article-title":"Migration and psychosis: a meta-analysis of incidence studies.","volume":"50","author":"Selten","year":"2020","journal-title":"Psychol Med"},{"issue":"1","key":"ysc260004r45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1017\/S0033291721001410","article-title":"Polygenic liability, stressful life events and risk for secondary-treated depression in early life: a nationwide register-based case-cohort study.","volume":"53","author":"Musliner","year":"2023","journal-title":"Psychol Med"},{"issue":"11","key":"ysc260004r46","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jamapsychiatry.2022.2742","article-title":"Penetrance and pleiotropy of polygenic risk scores for schizophrenia, bipolar disorder, and depression among adults in the US Veterans Affairs Health Care System.","volume":"79","author":"Bigdeli","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"ysc260004r47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/schbul\/sbt114","article-title":"Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies.","volume":"40","author":"Ra\u0161ic","year":"2014","journal-title":"Schizophr Bull"},{"issue":"4","key":"ysc260004r48","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.5331","article-title":"Polygenic scores and mood disorder onsets in the context of family history and early psychopathology.","volume":"8","author":"Freeman","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ysc260004r49","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jad.2024.09.107","article-title":"Person-level contributions of bipolar polygenic risk score to the prediction of new-onset bipolar disorder in at-risk offspring.","volume":"368","author":"Hafeman","year":"2025","journal-title":"J Affect Disord"},{"issue":"12","key":"ysc260004r50","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/s41591-020-1103-1","article-title":"Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome.","volume":"26","author":"Davies","year":"2020","journal-title":"Nat Med"},{"issue":"8","key":"ysc260004r51","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1038\/s41380-020-0654-3","article-title":"Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.","volume":"26","author":"Cleynen","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"1","key":"ysc260004r52","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1038\/s41467-021-26903-7","article-title":"Associations between patterns in comorbid diagnostic trajectories of individuals with schizophrenia and etiological factors.","volume":"12","author":"Krebs","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"ysc260004r55","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s13023-025-03941-8","article-title":"Bridging psychiatry and rare genetic diseases: a scoping review of therapeutic strategies and diagnostic delay paired with health care economic burden analysis.","volume":"20","author":"Garrison","year":"2025","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"ysc260004r56","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2025.101622","article-title":"Perceptions, knowledge, and attitudes toward genetics among psychiatric patients and their relatives: a systematic review and a meta-analysis.","volume":"28","author":"Prudhomme","year":"2026","journal-title":"Genet Med"},{"issue":"6","key":"ysc260004r57","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.biopsych.2016.06.028","article-title":"An examination of polygenic score risk prediction in individuals with first-episode psychosis.","volume":"81","author":"Vassos","year":"2017","journal-title":"Biol Psychiatry"},{"key":"ysc260004r58","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1017\/S0033291721005456","article-title":"Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study.","volume":"53","author":"Rodriguez","year":"2023","journal-title":"Psychol Med"},{"issue":"10","key":"ysc260004r60","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1176\/appi.ajp.2020.19111195","article-title":"Polygenic risk and progression to bipolar or psychotic disorders among individuals diagnosed with unipolar depression in early life.","volume":"177","author":"Musliner","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"6","key":"ysc260004r61","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/acps.13682","article-title":"A comprehensive analysis of age of onset and cumulative incidence of mental disorders: a Danish register study.","volume":"149","author":"Beck","year":"2024","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"ysc260004r62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1176\/appi.ajp.2019.18060721","article-title":"Polygenic risk score contribution to psychosis prediction in a target population of persons at clinical high risk.","volume":"177","author":"Perkins","year":"2020","journal-title":"Am J Psychiatry"},{"key":"ysc260004r64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.euroneuro.2024.01.005","article-title":"Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: a systematic review and meta-analysis of randomized controlled clinical trials.","volume":"81","author":"Milosavljevic","year":"2024","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10374","key":"ysc260004r65","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","article-title":"A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicenter, controlled, cluster-randomized crossover implementation study.","volume":"401","author":"Swen","year":"2023","journal-title":"Lancet"},{"issue":"10128","key":"ysc260004r66","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"ysc260004r67","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/wps.20771","article-title":"The clinical characterization of the adult patient with depression aimed at personalization of management.","volume":"19","author":"Maj","year":"2020","journal-title":"World Psychiatry"},{"issue":"1","key":"ysc260004r68","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/a-1288-1061","article-title":"Review and consensus on pharmacogenomic testing in psychiatry.","volume":"54","author":"Bousman","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"ysc260004r69","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/cpt.2748","article-title":"Pharmacogenomic testing and depressive symptom remission: a systematic review and meta-analysis of prospective, controlled clinical trials.","volume":"112","author":"Brown","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"51","key":"ysc260004r70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112560118","article-title":"High-impact rare genetic variants in severe schizophrenia.","volume":"118","author":"Zoghbi","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ysc260004r71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105195","article-title":"Contribution of copy number variants on antipsychotic treatment response in Han Chinese patients with schizophrenia.","volume":"105","author":"Sun","year":"2024","journal-title":"EBioMedicine"},{"issue":"4","key":"ysc260004r73","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s00115-024-01737-y","article-title":"Genetic diagnostics of mental health disorders in adulthood.","volume":"96","author":"Kilarski","year":"2025","journal-title":"Nervenarzt"},{"issue":"4","key":"ysc260004r74","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1521\/psyc.2011.74.4.315","article-title":"Genetic testing in psychiatry: a review of attitudes and beliefs.","volume":"74","author":"Lawrence","year":"2011","journal-title":"Psychiatry"},{"issue":"10","key":"ysc260004r75","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41431-022-01116-8","article-title":"Perceptions of causal attribution and attitudes to genetic testing among people with schizophrenia and their first-degree relatives.","volume":"30","author":"Cullen","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"ysc260004r76","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1007\/s10803-015-2489-3","article-title":"Parents\u2019 perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders.","volume":"45","author":"Reiff","year":"2015","journal-title":"J Autism Dev Disord"},{"key":"ysc260004r77","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2147\/NDT.S514514","article-title":"Transdiagnostic effects of schizophrenia polygenic scores on treatment outcomes in major psychiatric disorders.","volume":"21","author":"Serretti","year":"2025","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ysc260004r78","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.euroneuro.2021.11.005","article-title":"A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response.","volume":"55","author":"Fanelli","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"ysc260004r79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2022.02.015","article-title":"The potential of polygenic risk scores to predict antidepressant treatment response in major depression: a systematic review.","volume":"304","author":"Meerman","year":"2022","journal-title":"J Affect Disord"},{"issue":"6","key":"ysc260004r80","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1038\/s41380-020-0689-5","article-title":"Association of polygenic score for major depression with response to lithium in patients with bipolar disorder.","volume":"26","author":"Amare","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"11","key":"ysc260004r81","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/jamapsychiatry.2025.2039","article-title":"Polygenic contributions to lithium augmentation outcomes in unipolar depression.","volume":"82","author":"Kraft","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"3-4","key":"ysc260004r82","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000519707","article-title":"Association of attention-deficit\/hyperactivity disorder and depression polygenic scores with lithium response: a consortium for lithium genetics study.","volume":"7","author":"Coombes","year":"2021","journal-title":"Complex Psychiatry"},{"issue":"2","key":"ysc260004r83","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1001\/jamapsychiatry.2022.4234","article-title":"Associations between polygenic risk score loading, psychosis liability, and clozapine use among individuals with schizophrenia.","volume":"80","author":"Lin","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"ysc260004r84","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/s41380-023-01957-9","article-title":"The genetic basis of major depressive disorder.","volume":"28","author":"Flint","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"14","key":"ysc260004r85","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1017\/S0033291724002186","article-title":"Polygenic liabilities and treatment trajectories in early-onset depression: a Danish register-based study.","volume":"54","author":"Mundy","year":"2024","journal-title":"Psychol Med"},{"issue":"9","key":"ysc260004r86","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jaac.2020.12.033","article-title":"Polygenic risk and the course of attention-deficit\/hyperactivity disorder from childhood to young adulthood: findings from a nationally representative cohort.","volume":"60","author":"Agnew-Blais","year":"2021","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"ysc260004r87","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41398-020-00996-y","article-title":"Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores.","volume":"10","author":"Coombes","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"7","key":"ysc260004r88","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1001\/jamapsychiatry.2021.0701","article-title":"Polygenic liability and recurrence of depression in patients with first-onset depression treated in hospital-based settings.","volume":"78","author":"Musliner","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"ysc260004r89","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-021-01475-7","article-title":"Prognostic value of polygenic risk scores for adults with psychosis.","volume":"27","author":"Landi","year":"2021","journal-title":"Nat Med"},{"key":"ysc260004r91","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jad.2015.12.067","article-title":"Mortality and life expectancy in persons with severe unipolar depression.","volume":"193","author":"Laursen","year":"2016","journal-title":"J Affect Disord"},{"issue":"1-3","key":"ysc260004r92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2011.06.008","article-title":"Life expectancy among persons with schizophrenia or bipolar affective disorder.","volume":"131","author":"Laursen","year":"2011","journal-title":"Schizophr Res"},{"issue":"2","key":"ysc260004r93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/YCO.0b013e32835035ca","article-title":"Life expectancy and cardiovascular mortality in persons with schizophrenia.","volume":"25","author":"Laursen","year":"2012","journal-title":"Curr Opin Psychiatry"},{"issue":"6","key":"ysc260004r94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067133","article-title":"Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries.","volume":"8","author":"Laursen","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"ysc260004r95","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2215-0366(25)00123-3","article-title":"Association between genetic liability to physical health conditions and comorbidities in individuals with severe mental illness: an analysis of 2 cross-sectional observational studies in the UK.","volume":"12","author":"Kappel","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"ysc260004r96","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101202","article-title":"Return of genetic research results in 21,532 individuals with autism.","volume":"26","author":"Wright","year":"2024","journal-title":"Genet Med"},{"issue":"7966","key":"ysc260004r97","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41586-023-06079-4","article-title":"Polygenic scoring accuracy varies across the genetic ancestry continuum.","volume":"618","author":"Ding","year":"2023","journal-title":"Nature"},{"issue":"4","key":"ysc260004r98","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities.","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"ysc260004r99","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajhg.2021.11.008","article-title":"Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort.","volume":"109","author":"Priv\u00e9","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"10","key":"ysc260004r101","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1038\/s41380-022-01674-9","article-title":"Contribution of schizophrenia polygenic burden to longitudinal phenotypic variance in 22q11.2 deletion syndrome.","volume":"27","author":"Alver","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"2","key":"ysc260004r102","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/YPG.0000000000000385","article-title":"Unresolved ethical issues of genetic counseling and testing in clinical psychiatry.","volume":"35","author":"Perry","year":"2025","journal-title":"Psychiatr Genet"},{"issue":"6","key":"ysc260004r103","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036608","article-title":"Evidence-based genetic counseling for psychiatric disorders: a road map.","volume":"10","author":"Austin","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"ysc260004r104","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.4088\/JCP.14m09710","article-title":"A pilot randomized clinical trial evaluating the impact of genetic counseling for serious mental illnesses.","volume":"77","author":"Hippman","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"ysc260004r105","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113663","article-title":"Psychiatric genetic counseling for serious mental illness: impact on psychopathology and psychotropic medication adherence.","volume":"296","author":"Morris","year":"2021","journal-title":"Psychiatry Res"},{"key":"ysc260004r19","volume-title":"Preventive Medicine for the Doctor in His Community: an Epidemiologic Approach","author":"Leavell","year":"1958"},{"key":"ysc260004r21","volume-title":"Prevention of Mental Disorders: Effective Interventions and Policy Options","author":"World Health Organization","year":"2004"},{"key":"ysc260004r72","volume-title":"Exploring and Exploiting Genetic Risk for Psychiatric Disorders","author":"Davis","year":"2023"},{"key":"ysc260004r53","unstructured":"Royal College of Psychiatrists. The role of genetic testing in mental health settings. Accessed October 1, 2025. https:\/\/www.rcpsych.ac.uk\/docs\/default-source\/improving-care\/better-mh-policy\/college-reports\/College-report-CR237---Genetic-testing-in-mental-health-settings.pdf"},{"key":"ysc260004r54","unstructured":"International Society of Psychiatric Genetics. Genetic testing and psychiatric disorders: a statement from the International Society of Psychiatric Genetics. Accessed January 20, 2026, https:\/\/ispg.net\/genetic-testing-statement\/"},{"key":"ysc260004r59","doi-asserted-by":"crossref","unstructured":"Peyrot? WJ, Panagiotaropoulou? G, Olde Loohuis? LM, . Distinguishing different psychiatric disorders using DDx-PRS.? medRxiv. 2024:2024.02.02.24302228. doi:10.1101\/2024.02.02.24302228","DOI":"10.1101\/2024.02.02.24302228"},{"key":"ysc260004r63","doi-asserted-by":"crossref","unstructured":"Sharew? NT, Clark? S, Schubert? KO, Amare? AT. Pharmacogenomic Scores in Psychiatry: Systematic Review of Existing Evidence.? 2024;doi:10.1101\/2024.04.05.24305376","DOI":"10.1101\/2024.04.05.24305376"},{"key":"ysc260004r90","doi-asserted-by":"crossref","unstructured":"Musliner? KL, Steinbach? J, Goes? FS, Zandi? PP, Mortensen? PB, Vilhjalmsson? BJ. Do polygenic risk scores improve our ability to predict recurrent hospital admission in patients with bipolar disorder? Abstract presented at: Nordic Society of Human Genetics and Precision Medicine Annual Meeting 2022; November 4, 2022; Copenhagen, Denmark. https:\/\/nshg-pm2022.org\/wp-content\/uploads\/2022\/10\/Abstract-book-NSHG-PM-FAERDIG.pdf","DOI":"10.1016\/j.euroneuro.2022.07.449"},{"key":"ysc260004r100","doi-asserted-by":"crossref","unstructured":"Bybjerg-Grauholm? J, Pedersen? CB, B\u00e6kvad-Hansen? M, . The iPSYCH2012 case-cohort sample: updated directions for unravelling genetic and environmental architectures of severe mental disorders.? medRxiv. Preprint posted online December 2, 2020. doi:10.1101\/2020.11.30.20237768","DOI":"10.1101\/2020.11.30.20237768"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2852855\/jamapsychiatry_musliner_2026_sc_260004_1786118230.23312.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:30:49Z","timestamp":1787758249000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2852855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":105,"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.2583","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}